Latest Breaking News On - பரந்த புற்றுநோய் ப்ரோக்ர்யாம் - Page 1 : comparemela.com

Date Time MD Anderson and Broad Institute launch new translational research platform focused on rare cancers The University of Texas MD Anderson Cancer Center and the Broad Institute of MIT and Harvard today announced the launch of a new translational research platform to study rare cancers and develop a first-of-its-kind resource for the scientific community. The joint initiative will create a catalog of rare cancer models and provide a data resource to accelerate the identification of therapeutics to treat patients diagnosed with rare tumor types. The National Cancer Institute defines a rare cancer as one with fewer than 40,000 new cases per year. Cumulatively, rare cancers account for roughly one-quarter of all cancer cases and cancer deaths, but the low incidence of each different type of rare tumor presents a significant challenge to efforts to identify effective therapeutic approaches.

United statesTimothy heffernanWilliam sellersBroad cancer programBroad instituteUniversity of texas md anderson cancer centerNational cancer instituteRare tumor initiativeCancer centerTherapeutics discoveryCancer cell line factoryCancer dependency mapGiulio draettaஒன்றுபட்டது மாநிலங்களில்தீமோத்தேயு ஹெஃபர்னன்வில்லியம் விற்பனையாளர்கள்